Morphology and DNA degeneration during autoschizic cell death in bladder carcinoma T24 cells induced by ascorbate and menadione treatment

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 288, Issue 1, 2006, Pages 58-83

  Gilloteaux, Jacques ^a,d   Jamison, James M ^b   Arnold, David ^c   Neal, Deborah R ^b   Summers, Jack L ^b  

^a American University of the Caribbean School of Medicine   (United States)

^b Summa Research Foundation   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d American University of the Caribbean School of Medicine   (Netherlands Antilles)

Author keywords

Ascorbate; Bladder carcinoma; Cell death; DNA; Menadione

Indexed keywords

ACTIN; ASCORBIC ACID; DNA; MENADIONE; PHALLOIDIN;

APOPTOSIS; ARTICLE; AUTOSCHIZIC CELL DEATH; BLADDER CARCINOMA; CELL DEATH; CELL NUCLEUS; CELL ORGANELLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM; CYTOSKELETON; DNA DEGRADATION; FEULGEN STAINING; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; NECROSIS; PERIKARYON; PRIORITY JOURNAL; SUPERFICIAL CANCER;

ASCORBIC ACID; CARCINOMA; CELL DEATH; CELL LINE, TUMOR; DENSITOMETRY; DNA FRAGMENTATION; DRUG SYNERGISM; ELECTROPHORESIS; HISTOCYTOCHEMISTRY; HUMANS; ROSANILINE DYES; URINARY BLADDER NEOPLASMS; VITAMIN K 3;

EID: 30344486636     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.20276     Document Type: Article

References (146)

1. Agus DB, Vera JC, Golde DW. 1999. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 59:4555-4558.
2. Akman SA, Dietrich M, Chleboski RT, Limberg P, Block JB. 1985. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool. Cancer Res 45:5257-5262.
3. Arnold D, Gilloteaux J, Jamison JM, Summers JL. 1999. Synergistic effect of vitamin C: vitamin K3 on human renal adenocarcinoma cell line (CaKi-1)-scanning electron microscopy. Scanning 21:109-110.
4. Atkinson DE. 1968. The energy charge of the adenylate pool as a regulatory parameter: interaction with feedback modifiers. Biochemistry 7:4030-4040.
5. Barka T, Anderson PJ. 1965. Histochemistry: theory, practice and bibliography. New York: Hoeber Medical Division, Harper and Row. p 96-107.
6. Bellomo G, Mirabelli F, Vairetti M, Iosi F, Mallorni W. 1990. Cytoskeleton as target in menadione-induced oxidative stress in cultured mammalian cells: biochemical and immunocytochemical features. J Cell Physiol 143:118-128.
7. Benade L, Howard T, Burk D. 1969. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-2,3,4-triazole. Oncology 23:33-43.
8. Bindels Em, Vermey M, De Both NL, van der Kwast TH. 2001. Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines. Virch Arch 439:552-559.
9. Bram S, Froussard P, Guichard M, Jasmin C, Augery, Sinuossi-Barre F, Wray W. 1980. Vitamin C preferential toxicity for malignant melanoma cells. Nature 284:629-631.
10. Bram K, Fridovich I. 1981. DNA strand scission by enzymatically generated oxygen radicals. Arch Biochem Biophys 206:414-419.
11. Brunk UT, Zhang H, Dalen E, Illinger K. 1995. Exposure of cells to nonlethal concentration of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Radic Biol Med 19:813-822.
12. Bubeník J, Barešová M, Viklický V, Jakoubková J, Sainerová H, Donner J. 1973. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11:765-773.
13. Buc Calderon P, Cadrobbi J, Marques C, Hong-Ngoc N, Jamison JM, Gilloteaux J, Summers JL, Taper HS. 2002. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr Med Chem 9:2271-2285.
14. Burtnick LD, Chan KW. 1980. Protection of actin against proteolysis by complex formation with deoxyribonuclease I. Can J Biochem 58:1348-1354.
15. Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. 1983. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302:33-37.
16. Carbonera D, Azzone GF. 1988. Permeability of inner mitochondrial membrane and oxidative stress. Biochim Biophys Acta 943:245-255.
17. Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S. 2003. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97:2035-2042.
18. Cocco RE, Ucker DS. 2001. Distinct mode of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell 12:919-930.
19. Cohen GM, Stubberfield CR. 1990. Pyridine nucleotide changes in hepatocytes exposed to quinones. Free Radic Res Commun 8:355-363.
20. Comporti M. 1989. Three models of free radical-induced cell injury. Chem Biol Interact 72:1-56.
21. Cunningham CC. 1995. Actin polymerization and intracellular solvent flow in cell surface blebbing. J Cell Biol 129:1589-1599.
22. Daoust R, Amano H. 1963. Ribonuclease and deoxyribonuclase activities in experimental and human tumors by histochemical substrate film method. Cancer Res 23:131-134.
23. Daruwala R, Song J, Koh WS, Rumsey SC, Levine M. 1999. Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett 460:480-484.
24. De Laurenzi V, Melino G, Savini I, Annicchiarico-Petruzelli M, Finazi-Agro A, Avigliano L. 1995. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. Eur J Cancer 31A:463-466.
25. 3) treatment on human tumor cell growth in vitro: II, synergism with combined chemotherapy action. Anticancer Res 13:103-106.
26. Desai ID, Tappel AI. 1963. Damage to proteins by peroxidized lipids. J Lipid Res 58:204-207.
27. Desai ID, Sawant PL, Tappel AL. 1964. Peroxidative and radiation damage to isolated lysosomes. Biochim Biophys Acat 86:277-285.
28. De Tomasi JA. 1936. Improving the technique of the Feulgen stain. Stain Technol 11:137-144.
29. Dini L, Coppola S, Ruzittu MT, Ghibelli L. 1996. Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res 223:340-347.
30. Edgar JA. 1970. Dehydroxyascorbic acid and cell division. Nature 227:24-26.
31. 3-induced death of human bladder tumor cells. Scanning 20:210-211.
32. Falcieri E, Gobbi P, Zamai L, Vitale M. 1994a. Ultrastructural features of apoptosis. Scanning Microsc 8:653-666.
33. Falcieri E, Zamai L, Santi S, Cinti C, Gobbi P, Bosco D, Cataldi A, Betts C, Vitale M. 1994b. The behaviour of nuclear domains in the course of apoptosis. Histochemistry 102:221-231.
34. Falcieri E, Stuppia L, Di Baldassarre A, Mariani AR, Cinti C, Columbaro M, Zamai L, Vitale M. 1996. Different approaches to the study of apoptosis. Scanning Microsc 10:227-237.
35. Farber JL, Kyle ME, Coleman JB. 1990. The mechanisms of cell injury by activated oxygen species. Lab Invest 62:670-679.
36. Farber JL. 1994. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 102(Suppl 10):17-24.
37. Fawthrop DJ, Boobis AR, Davies DS. 1991. Mechanisms of cell death. Arch Toxicol 65:437-444.
38. Flora PK, Gregory CD. 1994. Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur J Immunol 24:2625-2632.
39. 3 combinations against human prostatic carcinoma cells. Scanning Microsc Int 9:159-173.
40. 3 on human bladder carcinoma T24 cells. Scanning 20:564-575.
41. 3 combinations against human T24 bladder carcinoma: another kind of cell death? Scanning 20:208-210.
42. 3 treatment. Mol Biol Cell 10:44A.
43. 3 treatment. Scanning 22:119-120.
44. Gilloteaux, J, Jamison JM, Arnold D, Summers JL. 2001a. Autoschizis: another cell death for cancer cells induced by oxidative stress. In: Motta PM, Machiarelli G, Nottola SA, editors. Advances in microanatomy of cells and tissues, Roma. Ital J Anat Embryol 106(Suppl 1):79-91.
45. Gilloteaux J, Jamison JM, Arnold D, Taper HS, Summers JL. 2001b. Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct Pathol 25:183-192.
46. Gilloteaux J, Jamison JM, Summers JL. 2001c. Cell death by autoschizis in human carcinoma cell lines: nucleus, DNA detection and degradation. Mol Cell Biol 12:497A.
47. 3 treatment. Microsc Microanal 9:1-19.
48. Gilloteaux J, Jamison JM, Arnold D, Jarjoura D, VonGreuningen V, Summers JL. 2003b. Autoschizis of human ovarian carcinoma cells: scanning electron and light microscopy of a new cell death induced by sodium ascorbate: menadione treatment. Scanning 25:137-149.
49. Gilloteaux J, Jamison JM, Lorimer HE, Jarjoura D, Taper HS, Calderon PB, Neal DR, Summers JL. 2004. Autoschizis: a new form of cell death for human ovarian carcinoma cells following ascorbate: menadione treatment. Nuclear and DNA degradation. Tissue Cell 36:197-209.
50. Gilloteaux J, Jamison JM, Neal DR, Summers JL. 2005. Cell death by autoschizis in TRAMP prostate carcinoma cells as a result of treatment by ascorbate: menadione combination. Ultrastruct Pathol 23:221-236.
51. Guaiquil VH, Farber CM, Golde DW, Vera JC. 1997. Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J Biol Chem 272:9915-9921.
52. Hacker G. 2000. The morphology of apoptosis. Cell Tissue Res 301:5-17.
53. Hart SP, Haslett C, Dransfield I. 1996. Recognition of apoptotic cells by phagocytes. Experientia 52:950-956.
54. Higgs HN, Pollard TD. 2001. Regulation of actin filament network formation trough ARP2/3 complex: activation by a diverse array of proteins. Annu Rev Biochem 70:649-676.
55. Hinshaw DB, Skalar LA, Bohl B, Schraufstatter IU, Hyslop PA, Rossi MW, Spragg RG, Cochrane CG. 1986. Cytoskeletal and morphological impact of cellular oxidant injury. Am J Pathol 123:454-464.
56. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA, Henson PM. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155:649-660.
57. Ingber DE. 1997. Integrins, tensegrity, and mechanotransduction. Gravit Space Biol Bull 10:49-55.
58. Ishida R, Takahashi T. 1975. Increased DNA chain breakage by combined action of bleomycin and superoxide radical. Biochem Biophys Res Commun 66:1432-1438.
59. 3 combinations against human prostate carcinoma cells. Tissue Cell 28:687-701.
60. Jamison JM, Gilloteaux J, Venugopal M, Koch JA, Nicastro E, Docherty JJ, Jasso J, Summers JL. 1997. Vitamin C and K3-induced oxidative stress in human prostate tumor cells: mitochondrial ultrastructural alterations. Microsc Microanal 3(Suppl 2):23-24.
61. Jamison JM, Gilloteaux J, Taper HS, Summers JL. 2001. Evaluation of the in vitro and in vivo antitumor activities of vitamin C and vitamin K3 combinations against human prostate cancer. J Nutr 131:158S-160S.
62. Jamison JM, Gilloteaux J, Taper HS, Calderon PB, Summers JL. 2002. Autoschizis: a novel cell death. Biochem Pharmacol 63:1773-1783.
63. Jamison JM, Gilloteaux J, Nassiri MR, Venugopal M, Neal DR, Summers JIL. 2004. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following vitamin C and vitamin K3 treatment. Biochem Pharmacol 67:337-351.
64. 3 combinations against prostate cancer. In: Lucas JL, editor. Trends in prostate cancer research, vol. 7. Hauppauge, NY: Nova Science Publishers. p 189-236.
65. Jarabak R, Jarabak J. 1995. Effect of ascorbate on the DT-diaphorase mediated redox cycling of 2-methyl-1,4-naphthoquinone. Arch Biochem Biophys 318:418-423.
66. Karnovsky MJ. 1967. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol 35:213-236.
67. Kato T, Ishikawa K, Nemoto R, Senoo A, Amano Y. 1978. Morphological characterization of two established cell line, T24 and MGH-U1, derived from human urinary bladder carcinoma. Tohoku J Exp Med 124:339-349.
68. Kerr JFR. 1971. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105:13-20.
69. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
70. Koch CJ, Biaglow JE. 1978. Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells. J Cell Physiol 94:299-306.
71. Kovar DR, Pollard TD. 2004. Insertional assembly of actin filament barbed ends in association with formins produces piconewton forces. Proc Natl Acad Sci USA 101:14725-14730.
72. Kuo SM, Tan D, Boyer JC. 2004. Cellular vitamin C accumulation in the presence of copper. Biol Trace Elem Res 100:125-136.
73. Lesko SA, Lorentzen RJ, Ts'o PO. 1980. Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 24:3023-3028.
74. Leung PY, Miyashita K, Young M, Tsao CS. 1993. Cytologic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res 13:475-480.
75. Levanon D, Manov U, Iancu TC. 2004. Qualitative and quantitative analysis of the effects of acetaminophen and N-acetylcysteine on the surface morphology of Hep3B hepatoma cells in vitro. Ultrastruct Pathol 28:3-14.
76. Liang W-J, Johnson D, Jarvis SM. 2001. Vitamin C transport systems of mammalian cells. Mol Memb Biol 18:87-95.
77. Liotti FS, Menghini AR, Guerrieri P, Talesa V, Bodo M. 1984. Effects of ascorbic acid and dehydroascorbic acid on the multiplication of tumor ascite cells in vitro. J Cancer Res Clin Oncol 108:230-232.
78. Litynska A, Przybylo M, Pochec E, Laidler P. 2002. Adhesion properties of human bladder cell lines with extracellular matrix components: the role of integrins and glycosylation. Acta Biochim Pol 49:643-650.
79. Lupulescu A. 1991. Vitamin C inhibits DNA, RNA and protein synthesis in epithelial neoplastic cells. Int J Vitam Nutr Res 61:125-129.
80. Lupulescu A. 1992. Ultrastructure and cell surface studies of cancer cells following vitamin C administration. Exp Toxicol Pathol 44:3-9.
81. Majno G, LaGattula M, Thompson TE. 1960. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virch Arch Pathol Anat 333:421-465.
82. Majno G, Joris I. 1995. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol 146:3-15.
83. Malorni W, Iosi F, Mirabelli F, Belomo G. 1991. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: alterations underlying surface blebs formation. Chem Biol Interact 80:217-235.
84. Maramag C, Menon M, Blaji KC, Reddy PG, Laxmanan S. 1997. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate 32:188-195.
85. Marshall CJ, Franks LM, Carbonell AW. 1977. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst 58:1743-1751.
86. Medina MA, Garcia de Veas R, Schweigerer L. 1994. Ascorbic acid is cytotoxic for pediatric tumor cells cultured in vitro. Biochem Mol Biol Int 34:871-874.
87. Menon MM, Maramag C, Malhotra RK, Seethalakshmi L. 1998. Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis. Cancer Biochem Biophys 16:17-30.
88. Milzani A, DalleDonne I, Colombo R. 1997. Prolonged oxidative stress on actin. Arch Biochem Biophys 339:267-274.
89. Minamitsuji-Mochizuki C, Mitaka T, Kojima T, Niitsu Y, Mochizuki Y. 1999. Spontaneous appearance of circular actin bands in cultured hepatocytes of adult rats. Med Electron Microsc 32:114-121.
90. Morgan AR, Cone RL, Elgert TM. 1976. The mechanism of DNA strand breakage by vitamin C and superoxide and the protective roles of catalase and superoxide dismutase. Nucl Acids Res 3:1139-1149.
91. Ngo EO, Sun TP, Chang JY, Wang CC, Chi KH, Cheng AL, Nutter LM. 1991. Menadione-induced DNA damage in a human tumor cell line. Biochem Pharmacol 42:1961-1968.
92. 3) treatment on human tumor cell growth in vitro. Cancer 63:901-906.
93. Nutter LM, Cheng AL, Hung HI, Hsieh RK, Ngo EO, Liu TW. 1991. Menadione: spectrum of anticancer therapy and effects on nucleoside metabolism in human neoplastic cell lines. Biochem Pharmacol 41:1283-1292.
94. O'Brien PJ. 1991. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 80:1-41.
95. Ohkuma S, Moriyama Y, Takano T. 1982. Identification and characterization of a proton pump on lysosomes by fluoresceinisothiocyanate-dextran fluorescence. Proc Natl Acad Sci USA 79:2758-2762.
96. 2+ in toxic cell killing. Trends Pharmacol Sc 10:281-285.
97. O'Toole CM, Povey S, Hepburn P, Franks LM. 1983. Identity of some human bladder cancer cell lines. Nature 301:429-439.
98. Park CH, Amare M, Savin MA, Hoogstraten B. 1980. Growth suppression for malignant leukemic cells in vitro by L-ascorbic acid. Cancer Res 40:1062-1065.
99. Pearse AGE. 1968. Histochemistry, theoretical and applied, vol. 1, 3rd ed. Boston: Little, Brown. p 646-648.
100. Pearse AGE. 1985. Histochemistry: theoretical and applied, 4th ed. Edinburgh: Churchill Livingstone. p 620-656.
101. Pedersen SF, Hoffmann EK, Mills JW. 2001. The cytoskeleton and cell volume regulation. Comp Biochem Physiol A Mol Integr Physiol 130:385-399.
102. Pething R, Gascoyne PRC, McLaughlin JA, Szent-Györgyi A. 1983. Ascorbate-quinone interactions: electrochemical, free radical and cytotoxic properties. Proc Natl Acad Sci USA 80:129-132.
103. Pierson HF, Meadows GG. 1983. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma. Cancer Res 43:2047-2051.
104. 3 (Menadione) inhibits the growth of mammalian tumor cells in culture. Life Sci 29:1387-1392.
105. Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. 1979b. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA 76:829-832.
106. Ren Y, Savill J. 1998. Apoptosis: the importance of being eaten. Cell Death Differ 5:563-568.
107. Reynolds CP, Perez-Polo JR. 1981. Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines. Neurosci Lett 23:151-155.
108. Sakagami H, Satoh K. 1997. Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17:3513-3520.
109. Sambrook RJ, Fritsch EF, Maniatis T. 1989. Molecular cloning, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
110. Saurin AT, Neubert H, Brennan JP, Eaton P. 2004. Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Nati Acad Sci USA 101:17982-17987.
111. Savill J. 1997. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491-508.
112. Sawant PL, Desai ID, Tappel AI. 1964. Factors affecting the lysosomal membrane and availability of enzymes. Arch Biochem Biophys 105:247-253.
113. Schindler M, Jiang LW. 1986. Nuclear actin and myosin as control elements in nucleocytoplasmic transport. J Cell Biol 102:859-862.
114. Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, O'Connor PM. 1995. Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochim Biophys Acta 1270:12-18.
115. Srigley JR, Hartwick WJ, Edwards V, deHarven E. 1988. Selected ultrastructural aspects of urothelial and prostatic tumors. Ultrastruct Pathol 12:49-65.
116. Stadtman ER. 1992. Protein oxidation and aging. Science 257:1220-1224.
117. Svitkina TM, Bulanova EA, Chaga OY, Vignjevic DM, Kojima S, Vasiliev JM, Borisy GG. 2003. Mechanism of filopodia initiation by reorganization of a dendritic network. J Cell Biol 160:409-421.
118. Taper HS. 1967. L'activité des nucléases et phosphatases acides et alcalines dans les tumeurs rénales induites chez le rat par la diméthylnitrosamine. Pathol Eur 2:406-420.
119. Taper HS, Brucher JM, Fort L. 1971. Alkaline and acid nucleases activity in the tumors of the human central nervous system. Cancer 28:482-490.
120. Taper HS. 1980. Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells. J Histochem Cytochem 29:1053-1060.
121. Taper HS, Deckers CO, Deckers-Passau LO. 1981. Increase in nuclease activity as a possible means for detecting tumor cell sensitivity to anticancer agents. Cancer 47:523-529.
122. 3 vitamin pretreatment. Int J Cancer 40:575-579.
123. Taper HS, Roberfroid M. 1992. Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 12:1651-1654.
124. 3 in mice bearing solid, transplantable tumor. Anticancer Res 16:499-503.
125. 3 combination. J Histochem Cytochem 49:109-119.
126. Taper HS, Jamison JM, Gilloteaux J, Summers JL, Calderon PB. 2004. Inhibition of the development of metastases by dietary vitamin C: K3 combination. Life Sci 75:955-967.
127. Tsao CS, Dunham WB, Leung PY. 1988. In vivo antineoplastic activity of ascorbic acid for human mammary tumor. In Vivo 2:147-150.
128. Van Aken E, De Wever O, Correia da Rocha AS, Marcel M. 2001. Defective E-cadherin/catenin complexes in human cancer. Virch Arch 430:725-751.
129. Varga JM, Airoldi L. 1983. Inhibition of transplantable melanoma tumor development in mice by prophylactic administration of Ca-ascorbate. Life Sci 32:1559-1564.
130. 3 against human prostate carcinoma cell lines. Cell Biol Intl 20:787-797.
131. 3 on human urologic tumor cell lines. Life Sci 59:1389-1400.
132. Vermes I, Clemeens H, Steffens-Nakken H, Reutlingsperger C. 1995. A novel essay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled annexin V. J immunol Meth 184:39-51.
133. Verrax J, Carobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper HS, Calderon PB. 2003. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death: basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem 38:451-457.
134. Verrax J, Cadrobbi J, Marques C, Taper HS, Habraken Y, Piette J, Calderon PB. 2004. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis 9:223-233.
135. +-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional space variant. Biochim Biophys Acta 1461:1-9.
136. Wang Y, Mackenzie B, Tsukaguchi H, Weremowicz S, Morton CC, Hediger MA. 2000. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Acta 267:488-494.
137. Watanabe N, Higashida C. 2004. Formins: progressive cappers of growing actin filaments. Exp Cell Res 301:16-22.
138. Waxman S, Bruckner H. 1982. The enhancement of 5-fuorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol. Eur J Cancer Clin Oncol 18:685-692.
139. Wu FY, Chang NT, Chen WJ, Juan CC. 1993a. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 8:2237-2244.
140. Wu FY, Liao WC, Chang HM. 1993b. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci 52:1797-1804.
141. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T. 1979. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci USA 76:4498-4502.
142. Wyllie AH, Kerr JFR, Currie AR. 1980. Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
143. Wyllie AH. 1981. Cell death: a new classification separating apoptosis from necrosis. In: Bowden D, Lockshin RA, editors. Cell death in biology and pathology. London: Chapman and Hall. p 9-34.
144. Wyllie AH, Morris RG, Smith AL, Dunlop D. 1984. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77.
145. Yamafuji K, Nakamura Y, Omura H, Soeda T, Gyotoku K. 1971. Antitumor potency of ascorbic acid, dehydroascorbic or 2,3-diketogulonic acid and their action on deoxyribonucleic acid. Z Krebsforsch Onkol Cancer Res Clin Oncol 76:1-7.
146. 3. Anticancer Res 21:3439-3444.